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Abstract
Background: Administrative databases are widely available and have been extensively used to provide estimates of
chronic disease prevalence for the purpose of surveillance of both geographical and temporal trends. There are,
however, other sources of data available, such as medical records from primary care and national surveys. In this paper
we compare disease prevalence estimates obtained from these three different data sources.
Methods: Data from general practitioners (GP) and administrative transactions for health services were collected
from five Italian regions (Veneto, Emilia Romagna, Tuscany, Marche and Sicily) belonging to all the three macroareas of
the country (North, Center, South). Crude prevalence estimates were calculated by data source and region for
diabetes, ischaemic heart disease, heart failure and chronic obstructive pulmonary disease (COPD). For diabetes and
COPD, prevalence estimates were also obtained from a national health survey. When necessary, estimates were
adjusted for completeness of data ascertainment.
Results: Crude prevalence estimates of diabetes in administrative databases (range: from 4.8% to 7.1%) were lower
than corresponding GP (6.2%-8.5%) and survey-based estimates (5.1%-7.5%). Geographical trends were similar in the
three sources and estimates based on treatment were the same, while estimates adjusted for completeness of
ascertainment (6.1%-8.8%) were slightly higher. For ischaemic heart disease administrative and GP data sources were
fairly consistent, with prevalence ranging from 3.7% to 4.7% and from 3.3% to 4.9%, respectively. In the case of heart
failure administrative estimates were consistently higher than GPs’ estimates in all five regions, the highest difference
being 1.4% vs 1.1%. For COPD the estimates from administrative data, ranging from 3.1% to 5.2%, fell into the
confidence interval of the Survey estimates in four regions, but failed to detect the higher prevalence in the most
Southern region (4.0% in administrative data vs 6.8% in survey data). The prevalence estimates for COPD from GP data
were consistently higher than the corresponding estimates from the other two sources.
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Conclusion: This study supports the use of data from Italian administrative databases to estimate geographic
differences in population prevalence of ischaemic heart disease, treated diabetes, diabetes mellitus and heart failure.
The algorithm for COPD used in this study requires further refinement.
Keywords: Prevalence, Chronic disease, Validation studies, Data reuse
Background
Administrative healthcare data are collected by privately
owned health maintenance organisations or government-
run institutions for managerial reasons. Due to differences
in healthcare systems, the content of the administrative
data may vary from country to country. They may contain
records collected at hospital discharge, during encoun-
ters with the general practitioner (GP) or specialist, at
drug prescription or dispensation, or upon request for, or
conduct of, a diagnostic analysis or procedure. The con-
tent also depends on the choices of the organisation: data
may or may not contain diagnosis codes; drug prescrip-
tions may or may not contain indication of use, data from
laboratories may or may not contain the actual result.
Secondary use of administrative healthcare data has
been increasing over the years, including the provision
of prevalence estimates for chronic diseases [1], such
as diabetes mellitus, chronic obstructive pulmonary dis-
ease (COPD), hypertension, ischaemic heart disease, cere-
brovascular disease, and depression. Case finding and
ascertainment algorithms are tailored to the structure
and type of information that is captured in the spe-
cific administrative database. Sensitivity and specificity of
such algorithms are conditioned on distinguishing fea-
tures such as presence of drug dispensing as well as
sources for diagnostic codes. The Canadian [2], Swedish
[3] and Medicare [4] administrative databases, for exam-
ple, contain diagnosis codes from hospitalization episodes
as well as from outpatient care, hence enriching the data
for estimation of chronic disease prevalence. In settings
where outpatient care diagnoses are not available, other
solutions have been explored. For instance, in Luxem-
bourg and France, where only drug prescriptions are
available, diabetes could be identified in treated patients
by analysing the volume of prescriptions for anti-diabetic
drugs [5].
Observational studies based on administrative
databases need careful validation of the algorithms they
rely on in order to provide sound epidemiologic research
[6]. Validation of chronic disease case ascertainment
algorithms has been performed either through direct
[7] or indirect [8] clinical assessment or through indi-
vidual record linkage with other electronic data sources,
such as disease registries [9] or health surveys [4,10].
When individual record linkage with non-administrative
data sources was not feasible, the performance of the
algorithms has been inferred though external comparison
with prevalence estimates obtained from health surveys
[5,11].
Italy has a tax-based, universal coverage national health
system organised in three levels: national; regional (21
regions); and local (on average 10 local health units per
region) [12]. Administrative data on healthcare reim-
bursed by the system, such as inpatient care and drug
dispensations, are routinely collected by local health units
and, in some regions, sent to the regional level. Trans-
mission to the national level is obligatory, and a common
data model for data transmission is mandated by law
on a national level. Before data are sent to the national
level, however, unique personal identifiers are removed,
hence record-linkage cannot be performed outside a sin-
gle region. The Italian administrative databases therefore
form a virtual national information system, with homo-
geneous data collected at the local level. Actual databases
allowing record-linkage only exist up to the regional level.
Data on diagnosis collected in outpatient settings are
not part of the Italian administrative databases, there-
fore algorithms for case ascertainment developed in other
countries that make use of this information cannot be
applied to the Italian situation. Several studies have inves-
tigated the comparison between chronic disease preva-
lence estimates from Italian administrative data and other
Italian data sources [11,13]. However studies to date
were only performed within local or regional databases.
Capture–recapture technique, a more sophisticated anal-
ysis aimed at estimating a suspected underascertainment
when more than two lists of cases are available [14,15],
was applied as well in estimating diabetes prevalence from
administrative databases, in specific geographic areas of
the country [16,17]. In light of the strong difference in
health and healthcare quality across Italy [18] it is relevant
to understand whether administrative databases can sup-
port chronic disease prevalence surveillance in different
areas of the country.
In 2010 the Italian national project VALORE was
launched aimed at assessing quality of care for chronic
diseases in five different Italian regions, based on sec-
ondary use of data from administrative databases. In this
study we describe prevalence estimates for diabetes melli-
tus, heart failure, ischaemic heart disease and COPD from
these data and compare the estimates with prevalence
estimates obtained from a national GP electronic medi-
cal record database and, where possible, from a national
health survey.
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Methods
Setting
The five regions which contributed data to the VALORE
study were: Veneto (A, Northern Italy), Emilia Romagna
(B, Northern Italy), Tuscany (C, Central Italy), Marche (D,
Central Italy) and Sicily (E, Southern Italy). The following
data files were used in the VALORE project:
Hospital discharge records with one main and five
secondary diagnoses coded using the International
Classification of Diseases, Ninth Revision, Clinical
Modification (ICD9CM);
Drug dispensing records coded using Anatomic
Therapeutic Chemical (ATC) codes for drug
classification; the ATC system is the drug
classification system adopted by the World Health
Organization [19];
Disease-specific exemptions from copayment to
health care coded using ICD9CM;
Inhabitant Registry (IR) with demographic
information (birthyear, gender) and identifier of the
GP in charge.
In each region, record-linkage within and between data
files was done deterministically with a unique coded per-
sonal identifier. Region B could not provide the file of
exemptions from copayment. For organizational reasons,
the regions participating in the VALORE project did not
provide administrative data of the whole regional popu-
lation, but only of specific geographical subareas. In each
region raw data were extracted from the local data files
and sent via File Transfer Protocol (FTP) to a single data
management center, after anonymization of the coded
personal identifier. A standardized automated routine was
developed in Stata 9.2 to apply the case ascertainment
algorithm and to calculate the prevalence estimates. Each
regional sample consisted of all inhabitants registered in
the selected geographical subareas and alive at the index
date (January 1st 2009).
Case ascertainment
The case finding and ascertainment algorithms that were
used to detect the specific diseases are shown in Table 1.
Regional administrative databases link Hospital discharge
records (HOSP), Drug dispensation records (DRUG), and
Disease-specific exemptions (EXE) from 2003 to 2008,
and a patient was classified as having the selected dis-
ease if at least one of the corresponding conditions listed
in Table 1 were met, i.e. condition 1 OR condition 2 OR
condition 3. For 93% of the population, the full six years
of follow-up data were available and were included in the
analysis.
Diverse algorithms for diabetes, COPD and ischaemic
heart disease case ascertainment from Italian adminis-
trative databases have been previously described in the
literature. Those published in Simonato et al. [20] were
the result of a workgoup involving two Italian scientific
associations of epidemiologists and biostatisticians, and
were therefore adopted. However, to deal with a previ-
ously reported issue of lack of sensitivity, the algorithm
for COPD was enriched with drug dispensing data [21]. In
addition we also calculated a prevalence estimate of dia-
betes based on anti-diabetic treatment alone. The heart
failure algorithm was defined in the VALORE project.
Comparison data
The Health Search Database (HSD) collects electronic
medical record data from a network of Italian GPs who
are members of the Italian College of General Practition-
ers [22]. The GPs participating in HSD all use the same
information software, in which they record demographic
information, visits and referrals, diagnoses (both in free
text and ICD9CM codes), drug prescriptions and clinical
information. For this study, data from 199 GPs practic-
ing in one of the five regions of the VALORE project were
used. The study population comprised patients aged 16-
95 who had been enrolled for at least two years and were
alive on 1st January 2009. Prevalence estimates were cal-
culated based on the number of patients enrolled with
the GPs at the index date (January 1st 2009) as denomi-
nator. The numerator represented all cases with specific
diseases as ascertained through a query in the PROBLEM
field of the clinical database, where diagnoses are coded.
The diagnosis codes are shown in Table 1.
The Italian National Health Survey is conducted every
five years by the National Institute of Statistics (ISTAT).
In addition, there is a yearly survey that captures rele-
vant health-related issues, and in particular diabetes and
COPD. The 2008 survey in the five regions of the VALORE
study comprised 11,656 people aged 16 years and above.
The survey sample was extracted according to a two-stage
weighted cluster sampling design (first level: municipal-
ities; second level: families). Answers to two questions
were used for this study: Are you affected by one or more of
the following chronic diseases? Diabetes (Yes/No) Chronic
bronchitis, emphisema, repiratory failure (Yes/No). Ques-
tions about heart failure and ischaemic heart disease were
not asked.
Data analysis
Administrative data provided estimates of prevalence in
three different ways: (1) analysis of distribution of preva-
lence per GP practices; (2) pooled analysis; (3) capture-
recapture analysis. While (2) and (3) provided estimates
that could be compared with the regional estimates from
the other two data sources, it must be noted that as
the population sample from each regional population is
not random, but rather geographically restricted, it was
expected that the comparison was biased. The rationale
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Table 1 Case ascertainment algorithms for diabetes, ischaemic heart disease, heart failure and COPD
Disease Administrative data GP data
HOSP DRUG EXE PROBLEM
(ICD9CM)+ (ATC)++ (ICD9CM) (ICD9CM)
Diabetes mellitus 250* A10 250 250*
Treated diabetes A10 250* AND
A10++++
Ischaemic heart disease 410-*414* C01DA 414 410-*414*
Heart failure 428*, 40201, - 428 428*, 40201,
40211, 40291, 40211, 40291,
40401, 40403, 40401, 40403,
40411, 40413, 40411, 40413,
40491, 40493 40491, 40493
COPD 490*-492*, R0+++ - 490*-492*,
494*, 496* 494*, 496*
Algorithms for case ascertainment of diabetes, ischaemic heart disease, heart failure, and chronic obstructive pulmonary disease (COPD), respectively from regional
administrative databases and from GP databases. Regional administrative databases link Hospital discharge records (HOSP), Drug dispensation records (DRUG), and
Disease-specific exemptions (EXE) from 2003 to 2008, and a patient was classified as having the selected disease if at least one of the listed conditions were met, ie
condition 1 OR condition 2 OR condition 3. GP databases were queried in the PROBLEM field of the clinical database, where diagnosis are coded.
+ Either in main or in one of the secondary diagnoses.
++ At least two dispensations in different dates in a single year.
+ + + A specific algorithm involving number, heterogeneity of ATC codes and time span of dispensations is used, see [21].
+ + ++ Patients having at least 2 prescriptions in one of the previous 2 years.
for analysis (1) was therefore the following: as both admin-
istrative and GP data could be aggregated per practice and
as practices could be considered to be (non randomly)
sampled from the same population of regional practices,
if the two measurement techniques (administrative versus
GP data) did measure in fact the same population param-
eter it was expected that the pairs of regional distributions
overlapped and distributions within the same region were
more similar to each other than distributions within the
same data source.
All the analyses refer to the population aged ≥ 16 years,
both male and females, although in the GP database ages
above 95 were truncated. Sex and age distribution of each
regional sample were computed. The percentage of the
regional population covered by the sample was estimated
by dividing its number by the estimates of the regional
population according to the National Institute of Statis-
tics [23]. Prevalence was estimated as the total number
of existing cases divided by the number of subjects in the
sample. Every adult Italian inhabitant is entitled to choose
a GP, and GPs may accept a maximum of 1,500 patients
[12]. For eachGP the population registered with that GP at
the index date was calculated and used as denominator for
the prevalence estimates. Median and interquartile (IQ)
range of this distribution was computed in each regional
sample. To avoid spurious results the disease prevalence
per GP practice was computed only for those practices
who had at least 300 people enrolled and at least 4 patients
with the disease.
In the Health Search Database the same prevalence
measures were estimated, the sample being the number of
inhabitants in charge of the GPs of HSD at the index date.
From the National Health Survey the variable of the
first-level sampling design (municipalities) was not avail-
able, hence simple weighted analysis was performed, with
probability weight attributed to each individual.
Finally, to ascertain the degree of completeness in cap-
turing diabetes cases from administrative data, a capture-
recapture analysis was performed. Log-linearmodels were
estimated by sequentially incorporating pair-wise depen-
dency between sources, and model selection was based on
the Akaike information criterion (AIC) criterion. This was
not done for region B, where only two sources of data were
available, since independence between two data sources
could not be assumed [15].
All analyses were performed with Stata 9.2.
Ethical approval
No identifiable human data were used for this study. The
dataset used in the study is not openly available. Per-
mission to use non-identifiable, individual data extracted
from administrative databases for the VALORE project
was granted by ULSS 16 Padova, ASP 7 Ragusa, Assesso-
rato Politiche per la Salute Emilia Romagna, Zona Terri-
toriale Senigallia, which are responsible for the use of the
data of the corresponding populations. Agenzia regionale
di sanita` della Toscana is enabled by a regional law to use
Tuscan data for research purposes. Approval for use of
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Table 2 Subpopulations covered by administrative, GP and survey data
Region Population
aged 16+
(millions)
Administrative data coverage GP data coverage Survey data coverage
N GPs N sample % pop N GPs N sample % pop N sample % pop
A 4.2 140 167,805 4.0 51 70,301 1.7 2,551 0.06
B 3.7 625 840,546 22.5 41 60,59 1.6 2,317 0.06
C 3.2 511 498,084 15.5 29 36,908 1.1 2,410 0.07
D 1.3 57 63,125 4.7 18 24,912 1.8 1,728 0.13
E 4.2 231 264,902 6.3 60 84,483 2.0 2,650 0.06
Characteristics of the subpopulations of each region covered, respectively, by administrative, GP and National Health Survey data. Data on general population from
the Italian National Institute of Statistics. Analysis is restricted to inhabitants aged 16+ and, for GP data, 16-95.
encrypted and aggregated data from the HSD was also
obtained from the Italian College of General Practitioners.
Data from the National Health Survey are openly available
from ISTAT.
Results
The subpopulations whose data were collected covered a
percentage of the total population of the regions, as shown
in Table 2.
The age distribution of the three population samples in
the five regions is shown in Figure 1. There were some dif-
ferences in age distribution between the populations from
the different sources (see Figure 1).
The prevalence estimates in the five regions from the
three sources are shown in Figure 2 and Table 3. Adminis-
trative data underestimated the prevalence of diabetes as
compared to both GP and survey estimates across most
regions although differences were often barely or non
significant and the increasing North-South trend could
be consistently observed in the three sources. Adjuste-
ment for underascertainment led to higher estimates with
respect to both GP and Survey figures, except in one
region. The width of the interquartile range (IQ) of the
practice-level estimates was higher in GP data than in
administrative databases. When prevalence of diabetes
was estimated based only on diabetes treatment, the
prevalence estimates obtained from GP data were fairly
consistent with those obtained from administrative data
in all regions; the width of the IQ range of the practice
estimates was similar between GP data and administrative
data in all regions.
The prevalence of ischaemic heart disease, as estimated
using administrative data, was similar to that estimated
using GP data, prevalence ranging from 3.3% (region A,
source GP) to 4.9% (region B, source GP). The width of the
IQ range was similar between GP data and administrative
data in all regions.
The prevalence estimates for heart failure were lower
in GP data than in administrative data in three regions,
with the highest difference (1.1% vs 1.4%) observed in both
regions A and C, where significativeness was observed
as well. According to age-specific prevalence estimates
shown in Figure 3, the difference in estimates were
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Figure 1 Age distribution in each region from each data source. Age distribution in each region of the sample extracted from administrative
databases (Admin), of the sample extracted from clinical data collected by GPs participating to the Health Search Database (GP) and of the sample
participating to the National Health Survey (Surv).
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Figure 2 Prevalence estimates for diabetes mellitus, treated diabetes, ischaemic heart disease, heart failure and COPD from each data
source. Crude prevalence estimates for diabetes mellitus, treated diabetes, ischaemic heart disease, heart failure and COPD in 5 Italian regions,
according to administrative data (Admin) and clinical GP data (GP) and, for diabetes and COPD only, the National Health Survey (Sur). For diabetes
mellitus estimates from administrative data adjusted for ascertainment are also presented (Rec). On the left column prevalence is represented by
box plots of the distribution of the disease prevalence in GP practices: the central line is the median value, the box covers the interquartile range,
while wiskers range from a minimum to a maximum value except for some observations which are detected as outliers and are representes as
single dots or diamonds; comparison is only betweem GP and Admin data sources. On the right column prevalence is represented as global
estimate. Date: 1 January 2009 Population: male and females, aged 16+.
increasing with age. The width of IQ range of the practice
estimates was higher for GP data in three regions.
The prevalence estimates from administrative data for
COPD in regions A to D fell within the confidence interval
of the survey estimates and ranged from from 3.8% (region
A) to 4.9% (regionD), but failed to detect the higher preva-
lence in Region E (4.0% in administrative data vs 6.8% in
survey data). The estimates from GP data were consis-
tently higher, ranging from 6.4% (region A) to 9.1% (region
E), and detected the same increased prevalence in region
E. The width of IQ range of the practice estimates was
much higher for GP data.
In all diseases the width of the IQ range of the prac-
tice estimates were fairly consistent across regions in
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administrative data. Mean and medians were pretty close
in both sources and all regions, and, except for outliers,
distributions were rather symmetric, although in GP data
data the distribution was slightly skewed to the right for
diabetes and COPD.
Discussion
Overall, differences in prevalence estimates among the
different sources in a region were lower than the differ-
ences between regions, and differences observed among
regions were similar across data sources. The fact that
independent sources of data showed consistent values
across different regions supports the claim that they cor-
respond to actual population measures. In case systematic
differences were observed, they could be interpreted as
being due to differences in data collection and associated
to demographic and disease characteristics. This provides
evidence that administrative data actually measure a pop-
ulation phenomenon that can be interpreted and supports
the use of administrative data for surveillance of geo-
graphical trends of the diseases in study, with the possible
exception of COPD.
In the case of diabetes mellitus, the observed concor-
dance between estimates from GP data and from sur-
vey data confirms previous reports [24,25]. Estimates
from GP data were systematically higher than estimates
from administrative data. According to reports from
other countries [26], the difference is likely to be due
to the proportion of patients who, although being diag-
nosed with diabetes to the knowledge of their GPs,
have mild or well-controlled disease and thus have never
had either a hospital admission or a prescription for
antidiabetic drugs, and have not received an exemption
from copayment of diabetes-related healthcare, there-
fore escaping the algorithm for administrative databases.
Indeed, when the subset of patients undergoing ther-
apy with antidiabetics in the previous two years were
extracted from both administrative and GP data sources,
the pairs of prevalence estimates almost coincided in all
of the regions, with one exception. Estimates adjusted
for completeness of ascertainment, on the other hand,
provided slightly higher estimates, a finding consistent
with a previous study with similar data in another Italian
area [16].
Ischaemic heart disease being congruently estimated by
administrative and GP data in all of the regions is an
unexpected finding. Angina, a less severe form of the dis-
ease, does not lead per se to a hospital admission, and
few cases (less than 5%) are detected by the registry of
exemptions from copayment. As around 30% of cases are
detected only by dispensings of nitrates (data not shown),
we observe that nitrates therapy is probably specific in
detecting cohorts bearing this condition, as otherwise
data would have been less consistent across regions in
matching the diagnosis-based figures from GP clinical
databases.
Heart failure was underestimated by GP data, although
non significantly in the majority of the regions. Underesti-
mation was highest in the oldest age band available in both
data sources (85-95), where the prevalence is highest. This
is consistent with the hypothesis that GPs belonging to
HSDmight occasionally perform less accurate data collec-
tion when visiting patients at home [27] or in residential
care [22], or consider heart failure as a complication of
other underlying conditions, such as ischaemic heart dis-
ease, rather than as a disease of its own. This would imply
that the population detected by administrative data had
a more severe form of the disease and was more often
affected by disability. Another possibility is that adminis-
trative database overestimate prevalence because of lack
of specificity of the case ascertainment algorithm. Indeed,
according to a recent review of validated algorithms for
case ascertainment of heart failure [28], algorithms using
secondary discharge diagnosis showed lower positive pre-
dictive value (PPV) in several countries.
For COPD administrative data failed to detect the dif-
ferences between regions that the other two sources
consistently measured. Ascertainment of COPD from
administrative sources has been shown to be challeng-
ing in other studies [29,30]. In this case, the algorithm
detected a particular pattern of drug prescriptions, com-
bining duration, intensity and ATC class, that had been
identified through a consensus process in a group of
experts that was reported in Anecchino et al. [21].
Although the pattern was specifically meant to avoid mis-
classification (e.g., with respect to asthma), it is possible
that the conclusions of the study were in fact specific for
the geographic area where the experts worked.
In light of the limitations of the sampling design of our
study, the overall good agreement with other data sources
supports a fortiori validity of chronic disease surveil-
lance using administrative data in the regions that were
involved in the study. However, support for external valid-
ity of our results needs to be discussed. Althought we
only collected data from few geographical areas, the same
administrative data are available for the whole national
population. We are in fact not claiming that administra-
tive data from few geographically sparse areas can be used
to estimate national prevalence of chronic diseases, but
rather that administrative data seem to be consistently
able to detect prevalence of some chronic diseases around
the area they were extracted from. Our positive findings
(treated diabetes, ischaemic heart disease, heart failure)
are indeed probably due to the fact that typical health
consumption patterns of such chronic patients are simi-
lar across regions. On the assumption that regions of the
same macroarea of the country (North, Center, South)
are similar the one to the other to this respect, our data
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Table 3 Table of prevalence estimates for diabetes mellitus, treated diabetes, ischaemic heart disease, heart failure and COPD from each data source
A B C D E
Disease Data source Mean Median Mean Median Mean Median Mean Median Mean Median
source (95% CI) (IQ Range) (95% CI) (IQ Range) (95% CI) (IQ Range) (95% CI) (IQ Range) (95% CI) (IQ Range)
Diabetes mellitus Admin 5.6 (5.5-5.7) 5.5 (4.8-6.4) 4.9 (4.9-5.0) 4.8 (4.1-5.7) 6.0 (6.0-6.1) 6.0 (5.1-6.9) 5.2 (5.0-5.4) 5.2 (4.9-5.7) 7.1 (7.0-7.2) 7.1 (6.0-8.0)
GP 6.2 (6.0-6.4) 5.9 (5.1-7.6) 6.3 (6.1-6.5) 5.6 (5.3-7.7) 6.3 (6.1-6.6) 6.4 (5.5-7.0) 6.7 (6.4-7.1) 6.3 (5.1-8.6) 8.5 (8.4-8.7) 8.8 (7.0-10.2)
Survey 5.1 (4.2-6.0) 6.1 (5.1-7.1) 6.1 (5.1-7.1) 6.3 (5.2-7.4) 7.5 (6.4-8.5)
Admin-Recap 7.6 (7.1-8.2) 7.0 (6.8-7.3) 6.0 (5.8-6.4) 8.7 (8.4-9.0)
Treated diabetes Admin 4.1 (4.0-4.2) 4.0 (3.4-4.8) 4.1 (4.0-4.1) 4.0 (3.3-4.9) 5.2 (5.1-5.3) 5.1 (4.4-5.9) 4.1 (3.9-4.2) 4.0 (3.6-4.6) 6.0 (6.0-6.1) 6.0 (5.1-6.9)
GP 3.8 (3.7-3.9) 3.7 (2.9-4.8) 3.9 (3.8-4.1) 3.7 (3.2-4.7) 4.1 (3.9-4.3) 4.0 (3.3-4.8) 3.9 (3.7-4.2) 3.7 (3.2-4.4) 5.9 (5.8-6.1) 6.0 (4.7-7.3)
Ischaemic heart disease Admin 3.7 (3.6-3.8) 3.6 (3.0-4.3) 4.7 (4.6-4.7) 4.6 (3.8-5.6) 4.0 (4.0-4.1) 3.9 (3.3-4.7) 4.3 (4.1-4.4) 4.2 (3.4-5.0) 3.9 (3.9-4.0) 3.8 (3.1-4.6)
GP 3.3 (3.2-3.5) 3.1 (2.5-4.1) 4.9 (4.7-5.0) 4.6 (3.6-5.9) 3.8 (3.6-4.0) 3.5 (3.2-4.3) 4.1 (3.8-4.3) 4.0 (3.2-4.9) 4.4 (4.2-4.5) 4.1 (3.3-4.8)
Heart failure Admin 1.4 (1.3-1.4) 1.3 (1.1-1.7) 1.5 (1.5-1.5) 1.4 (1.1-1.9) 1.4 (1.4-1.4) 1.4 (1.1-1.7) 1.2 (1.1-1.3) 1.2 (0.9-1.4) 1.2 (1.1-1.2) 1.2 (0.9-1.5)
GP 1.1 (1.0-1.1) 0.9 (0.7-1.4) 1.5 (1.4-1.6) 1.2 (0.6-1.8) 1.1 (1.0-1.2) 0.8 (0.6-1.4) 1.5 (1.4-1.7) 1.1 (0.8-1.4) 1.0 (0.9-1.1) 0.8 (0.5-1.3)
COPD Admin 3.1 (3.0-3.1) 3.3 (2.5-3.7) 5.1 (5.1-5.2) 5.0 (4.1-6.0) 4.7 (4.6-4.7) 4.7 (3.9-5.4) 5.2 (5.1-5.4) 5.2 (4.7-5.9) 4.0 (3.9-4.1) 3.8 (3.2-4.6)
GP 6.4 (6.2-6.6) 5.1 (3.8-8.7) 8.3 (8.1-8.5) 6.7 (3.9-10.3) 6.8 (6.5-7.1) 6.5 (3.6-8.6) 7.3 (7.0-7.7) 5.4 (3.4-8.6) 9.1 (8.9-9.2) 7.7 (5.3-11.0)
Survey 3.8 (3.0-4.6) 5.4 (4.4-6.4) 4.8 (3.9-5.7) 4.9 (3.8-5.9) 6.8 (5.8-7.8)
Crude prevalence estimates for diabetes mellitus, treated diabetes, ischaemic heart disease, heart failure and COPD in 5 Italian regions, according to administrative data (Admin) and clinical GP data (GP). For diabetes and
COPD only: crude prevalence estimated from the National Health Survey (Surv). For diabetes only: prevalence estimates from administrative data adjusted for estimated completeness of ascertainment (Admin-Recap).
Prevalence estimated both as global percentage with 95% confidence interval and, for Admin and GP only, as median with interquantile range of the distribution of prevalence in GP practices. Date: 1 January 2009.
Population: male and females, aged 16-95 in GP and 16+ in the other sources.
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Figure 3 Age-specific prevalence of heart failure. Age-specific
prevalence of heart failure in 5 Italian regions, according to
administrative data (Admin) and clinical GP data (GP). Date: 1 January
2009 Population: male and females, aged 16+.
support the claim that estimates relying on the same algo-
rithms should prove to be similarly effective. However, in
some specific critical areas of the country where incom-
plete administrative data collection is suspected, a local
evaluation is recommended.
Cohorts can be selected from administrative databases
to perform population-based studies on patients with
chronic diseases through further record-linkage with the
same databases. This study cannot provide analytical tools
to assess the limitations of the findings of such studies.
However, no evidence emerges for major bias, except in
the case of COPD, where regional differences with the
other data sources are likely to be due to differences in the
characteristics of the corresponding local cohorts.
Limitations
The first limitation of studies that make secondary use of
existing healthcare data sources is that only prevalence of
diagnosed cases is taken into account, and underestima-
tion of actual population prevalence cannot be estimated
[31].
An implicit assumption of both crude and adjusted rate
estimation from administrative databases performed in
this study was that PPV of the case detection was 100%, an
assumption that we could not verify and that is not to be
taken for granted, when, for instance, secondary discharge
diagnosis or drug utilisation with no indication is used as a
source of case ascertainment. Ecological validation studies
cannot directly resolve this issue, as consistent ecological
estimates between a data source and a reference gold stan-
dard might as well be due to coincidental inclusion of false
positive and exclusion of false negative cases. Only valida-
tion studies perfomed using individual-level comparison
with a gold standard could assess PPV and sensitivity.
Conclusion
This study supports the use of data from Italian admin-
istrative databases to estimate geographic differences in
population prevalence of ischaemic heart disease, treated
diabetes, diabetes mellitus and heart failure. The algo-
rithm for COPD used in this study requires further refine-
ment.
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